BioDigital Inc.

Based in the US, BioDigital Inc. specializes in creating interactive 3D visualizations of human anatomy and health conditions, enhancing medical education and patient engagement through an advanced software platform. BioDigital Inc. develops tools for visualizing human anatomy and diseases.

Founded in 2013 in New York, US, by Aaron Oliker, Frank Sculli, and John Qualter, the company has completed 4 investment deals. The latest funding occurred in January 2025, where it raised USD 4. 00 mn in a Series A round led by FirstMark Capital and NYU Venture Capital. In January 2025, Anatomage, Inc.

acquired BioDigital Inc. from its investors for an undisclosed amount. BioDigital's primary offering is the BioDigital Human, an interactive 3D software platform designed to visualize human anatomy, diseases, and treatments. This platform allows users to create and manage customized 3D visualizations that can be integrated into various digital channels, catering to educational institutions, healthcare organizations, and medical device companies.

The platform serves over 5 million users globally and is marketed internationally, with significant presence in North America, Europe, and Asia. BioDigital generates revenue through a subscription model for its flagship product, the BioDigital Human, as well as through institutional licenses and partnerships with educational and healthcare providers. Revenue is also derived from custom visualization projects, reflecting the value of the interactive content provided to clients across the health and education sectors. Following the acquisition by Anatomage, Inc.

in January 2025, BioDigital plans to leverage its cloud-based medical visualization technology to enhance product offerings and broaden market reach. The acquisition is expected to facilitate entry into additional geographic regions and expand integration with Anatomage's existing solutions, thereby supporting the company’s growth initiatives.